All Stories

  1. Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis

    Article • Clinical Cosmetic and Investigational Dermatology, January 2018, Dove Medical Press

    Monica Rengifo Pardo, Lori Kim